Indian Council of Medical Research, ICMR has issued guidance on the use of Truenat beta CoV test which has been validated by the research body for undertaking a screening test for COVID-19. ICMR has advised all the states which intends to initiate Truenat beta CoV test that the proposed sites of Truelab  Workstation do not require approval of ICMR.

The states can appoint a core team of experts for assessing facilities with the Truelab Workstation for feasibility of initiating COVID-19 testing in the existing setup. It has also been advised that based on the evaluation of the core team, the designated officer of each state can accord approval for testing and the procurement of the cartridges for existing machines and other logistics should be done through the Central TB Division.

ICMR said that sample collection should only be done using the virus lysis buffer provided by the supplier as this is essential to avoid any bio-safety concerns.